The evolution of sunscreen products in the United States - A 12-year cross sectional study

Photochemical and Photobiological Sciences

Volumn 12, Issue 1, 2013, Pages 197-202

  Wang, Steven Q ^a   Tanner, Paul R ^b   Lim, Henry W ^c   Nash, J F ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4-TERT-BUTYL-4'-METHOXYDIBENZOYLMETHANE; ACRYLIC ACID DERIVATIVE; AVOBENZONE; CINNAMIC ACID DERIVATIVE; OCTOCRYLENE; OCTYLMETHOXYCINNAMATE; PROPIOPHENONE DERIVATIVE; SUNSCREEN; ZINC OXIDE;

ARTICLE; CHEMISTRY; CROSS-SECTIONAL STUDY; HUMAN; RADIATION PROTECTION; ULTRAVIOLET RADIATION; UNITED STATES;

ACRYLATES; CINNAMATES; CROSS-SECTIONAL STUDIES; HUMANS; PROPIOPHENONES; RADIATION PROTECTION; SUN PROTECTION FACTOR; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; UNITED STATES; ZINC OXIDE;

EID: 84871204655     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/c2pp25112d     Document Type: Article

References (23)

1. I. Nicol C. Gaudy J. Gouvernet M. A. Richard J. J. Grob Skin protection by sunscreens is improved by explicit labeling and providing free sunscreen J. Invest. Dermatol. 2007 127 41 48 (Pubitemid 46005659)
2. S. Darlington G. Williams R. Neale C. Frost A. Green A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses Arch. Dermatol. 2003 139 451 455 (Pubitemid 36427609)
3. R. P. Gallagher J. K. Rivers T. K. Lee C. D. Bajdik D. I. McLean A. J. Coldman Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial JAMA 2000 283 2955 2960 (Pubitemid 30414507)
4. T. K. Lee J. K. Rivers R. P. Gallagher Site-specific protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial J. Am. Acad. Dermatol. 2005 52 786 792 (Pubitemid 40614641)
5. A. Green G. Williams R. Neale V. Hart D. Leslie P. Parsons et al., Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial Lancet 1999 354 723 729 (Pubitemid 29405786)
6. J. C. van der Pols G. M. Williams N. Pandeya V. Logan A. C. Green Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use Cancer Epidemiol. Biomarkers Prev. 2006 15 2546 2548 (Pubitemid 46048320)
7. A. C. Green G. M. Williams V. Logan G. M. Strutton Reduced melanoma after regular sunscreen use: randomized trial follow-up J. Clin. Oncol. 2011 29 257 263
8. Food and Drug Administration, Labeling and effectiveness testing, Sunscreen drug products for over-the-counter human use http://www.gpo.gov/fdsys/ pkg/FR-2011-06-17/pdf/2011-14766.pdf, June 17, 2011
9. J. H. Rabe A. J. Mamelak P. J. McElgunn W. L. Morison D. N. Sauder Photoaging: mechanisms and repair J. Am. Acad. Dermatol. 2006 55 1 19 (Pubitemid 43867014)
10. R. Roelandts, History of photoprotection, in Clinical Guide to Sunscreens and Photoprotection, ed., H. Lim, and, Z. D. Draelos, Informa Healthcare, 2009, p. 1-11
11. S. Q. Wang J. W. Stanfield U. Osterwalder In vitro assessments of UVA protection by popular sunscreens available in the United States J. Am. Acad. Dermatol. 2008 59 934 942
12. S. Q. Wang J. M. Goulart H. W. Lim Lack of UV-A protection in daily moisturizing creams Arch. Dermatol. 2011 147 618 620
13. S. Q. Wang H. W. Lim Current status of the sunscreen regulation in the United States: 2011 Food and Drug Administration's final rule on labeling and effectiveness testing J. Am. Acad. Dermatol. 2011 65 863 869
14. P. J. Matts V. Alard M. W. Brown L. Ferrero H. Gers-Barlag N. Issachar et al., The COLIPA in vitro UVA method: a standard and reproducible measure of sunscreen UVA protection Int. J. Cosmet. Sci. 2010 32 35 46
15. S. Q. Wang S. W. Dusza Assessment of sunscreen knowledge: a pilot survey Br. J. Dermatol. 2009 161 Suppl 3 28 32
16. P. Autier M. Boniol G. Severi J. F. Dore Quantity of sunscreen used by European students Br. J. Dermatol. 2001 144 288 291 (Pubitemid 32178807)
17. A. Faurschou H. C. Wulf The relation between sun protection factor and amount of sunscreen applied in vivo Br. J. Dermatol. 2007 156 716 719 (Pubitemid 46452341)
18. E. Thieden P. A. Philipsen J. Sandby-Moller H. C. Wulf Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries Arch. Dermatol. 2005 141 967 973 (Pubitemid 46165520)
19. G. Watkins The importance of incorporating aesthetics into topical formulations Drug Delivery Technol. 2010 10 51 54
20. J. R. Gordon J. C. Brieva Images in clinical medicine. Unilateral dermatoheliosis New England J. Med. 2012 366 e25
21. M. Anderson, J. Hewitt and S. Spruce, Broad-spectrum physical sunscreens: titanium dioxide and zinc oxide, in Sunscreens: Development, Evaluation, and Regulatory Aspects, ed., N. Lowe, N. Shaath, and, M. Pathak, Marcel Dekker Inc, New York, 1997, pp. 353-399
22. Food and Drug Administration, Sunscreen drug products for over-the-counter human use, Marketing Status of Products Containing Avobenzone, Enforcement Policy, http://www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/ StatusofOTCRulemakings/ucm090435.pdf, April 30, 1997
23. Food and Drug Administration, Health and Human Services. Sunscreen drug products for over-the-counter human use, final monograph, Final rule, Fed Regist, http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/ DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm090244. pdf, May 21, 1999